Aris Xie Selected Research

APOBEC-1 Deaminase

1/2021	Echocardiographic Molecular Imaging of the Effect of Anticytokine Therapy for Atherosclerosis.
11/2018	Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging.
7/2015	Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.
1/2010	Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aris Xie Research Topics

Disease

10	Atherosclerosis 06/2022 - 07/2007
8	Ischemia 01/2021 - 11/2011
3	Infarction (Infarctions) 11/2018 - 08/2007
2	Myocardial Infarction 01/2021 - 11/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 10/2012
2	Rupture 07/2015 - 12/2012
2	Ventricular Remodeling 02/2014 - 08/2012
2	Inflammation (Inflammations) 01/2013 - 07/2007
2	Reperfusion Injury 10/2012 - 01/2010
1	Pathologic Constriction (Stenosis) 01/2021
1	Thrombotic Microangiopathies 01/2019
1	Hyperemia 05/2017
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2017
1	Peripheral Arterial Disease 03/2017
1	Hyperinsulinism (Hyperinsulinemia) 12/2014
1	Cardiomyopathies (Cardiomyopathy) 02/2014
1	Left Ventricular Dysfunction 02/2014
1	Flank Pain 12/2013
1	Pain (Aches) 12/2013
1	Hemorrhage 12/2012
1	Hypertension (High Blood Pressure) 08/2012
1	Neoplasms (Cancer) 08/2012
1	Diabetes Mellitus 11/2011
1	Vascular Remodeling 11/2011
1	Crush Injuries 09/2010
1	Necrosis 08/2007

Drug/Important Bio-Agent (IBA)

6	P-SelectinIBA 01/2016 - 08/2007
5	LDL Receptors (LDL Receptor)IBA 01/2021 - 01/2010
4	APOBEC-1 DeaminaseIBA 01/2021 - 01/2010
3	Glycoproteins (Glycoprotein)IBA 11/2018 - 10/2012
3	SelectinsIBA 01/2016 - 11/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 08/2012
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2022 - 07/2007
2	von Willebrand FactorIBA 10/2020 - 07/2015
2	AntioxidantsIBA 11/2018 - 01/2013
2	Contrast MediaIBA 12/2013 - 10/2012
2	Peptides (Polypeptides)IBA 09/2010 - 01/2010
1	ibrutinibIBA 06/2022
1	ponatinibIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 11/2018
1	DisintegrinsIBA 11/2018
1	ThrombospondinsIBA 11/2018
1	Peptide Hydrolases (Proteases)FDA Link 11/2018
1	FS 069 (Optison)FDA Link 05/2017
1	LipidsIBA 03/2017
1	SonazoidIBA 01/2016
1	PhosphatidylserinesIBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 07/2015
1	Vasodilator Agents (Vasodilators)IBA 04/2015
1	Insulin (Novolin)FDA Link 12/2014
1	Complement System Proteins (Complement)IBA 12/2013
1	acetovanillone (apocynin)IBA 09/2013
1	LuciferasesIBA 02/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012
1	Cell Adhesion MoleculesIBA 12/2012
1	LigandsIBA 10/2012

Therapy/Procedure

8	Therapeutics 01/2021 - 08/2012
6	Microbubbles 03/2017 - 01/2010
3	Ligation 11/2018 - 02/2013
1	Catheters 01/2021
1	Ultrasonic Therapy 03/2017
1	Intravenous Injections 03/2017